A large number of cerebral microbleeds in CADASIL patient presented with recurrent seizures: A case report

doi:10.21203/rs.2.9230/v1

Download PDF

Case report

A large number of cerebral microbleeds in CADASIL patient presented with recurrent seizures: A case report

https://doi.org/10.21203/rs.2.9230/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 30 May, 2019

Read the published version in BMC Neurology →

You are reading this older preprint version

Read the latest preprint version →

Background

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary arteriopathy associated with NOTCH3 gene. Clinical manifestations include strokes, transient ischemic events, psychiatric disturbances, dementia, as well as migraines. We report a case of a Thai man with severe phenotype of CADASIL presenting with recurrent seizures and acute ischemic stroke in whom classic vascular risk factors are also present.

Case presentation

A 50 year-old-man who has had history of mood disorder and progressive cognitive decline for 20 years as well as well-controlled diabetes mellitus and hypertension presenting with recurrent generalized seizures and acute right-sided weakness. The MRI of the brain showed acute infarction of the left pons, a large number of cerebral microbleeds throughout the brain and white matter abnormalities without classic anterior temporal lobe lesion. Molecular genetic testing identified homozygous pathologic variants, c.1672C>T (p. Arg558Cys) in the NOTCH3 gene. The diagnosis of CADASIL was confirmed. His clinical symptoms deteriorated, and he died of fever of unknown origin with secretion obstruction.

Conclusion

This case raises the awareness of an uncommon cause of acute ischemic stroke in patients with classic vascular risk factors and highlights the complete evaluation for an unexpected clinical presentation or unexpected diagnostic study results.

Internal Medicine Specialties

CADASIL

Cerebral microbleeds

NOTCH3 gene

Homozygous p.Arg558Cys

Case report

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most frequent genetic cause of stroke [1]. Clinical manifestations include strokes, transient ischemic events, psychiatric disturbances, dementia, and migraines [2]. The classic clinical presentation is a young or middle-aged adult experiencing ischemic stroke or transient ischemic attack and/or early onset dementia with subcortical leukoencephalopathy on brain imaging [2]. Seizures are uncommon symptoms which can be found in only 6% to 10% of cases [2-4]. The exact etiology of an epileptic seizures is not known. The common MRI findings are T2-hyperintensity lesions in periventricular and subcortical white-matter especially in the external capsule and anterior temporal lobes which are more likely to be involved in this condition compared to sporadic forms of small vessel diseases [5]. The prevalence of cerebral microbleeds ranges from 34% to 75% [3-4, 6-8]. Common locations of cerebral microbleeds are in the thalami, the basal ganglias, the subcortical white matter, the brainstem, the cerebellum and at the gray-white matter junction [7-8]. The diagnosis of CADASIL is identifying genetic changes in NOTCH3 gene located on chromosome 19 [1]. We report herein a Thai man with previous history of well-controlled diabetes mellitus and hypertension presenting with seizures and acute right-sided weakness. The MRI of the brain showed acute infarction in the left pons and numerous cerebral microbleeds throughout the brain.

A 50-year-old Thai male presented with three episodes of generalized seizures and right-sided hemiparesis for 6 hours before arrival. He has had no seizures before. He has history of well-controlled diabetes mellitus and hypertension for 20 years and takes metformin 1,000 mg/day and diltiazem 60 mg/day. His past medical history has revealed progressive slowness of thinking and walking, memory impairment, sleep-wake disturbance and mood disorder for 20 years. He was diagnosed with organic mood disorder 5 years before this presentation and treated by risperidone 0.5 mg/day, sertraline 50 mg/day, and trihexyphenidyl 1 mg/day. Notwithstanding the treatment, his symptoms has been progressively worsening for the past 1 year to the point that he could not perform activities of daily living such as taking correct medications. He is the fifth child of total of seven. His sister has history of unexplained hearing loss, cognitive decline, and slowness of movement starting at the age of 20. When she was 40 years old, she developed visual and auditory hallucinations as well as recurrent transient ischemic attacks with fully recovery. The patient’s father and mother were died at the age of 70 and 78, respectively without history of cognitive impairment or stroke. The mental status examination showed good level of consciousness; however, he muted and had slowed responsive to commands. The motor examination showed right-sided weakness (grade 2/5 for arm and grade 0/5 for leg) and generalized hyperreflexia except right leg hyporeflexia without sensory impairment. There was also a mild right facial weakness. The CT of the brain showed diffuse white matter abnormalities, old multiple lacunar infarctions at bilateral basal ganglias, thalami, and left pons. The initial diagnosis was acute ischemic stroke with seizure. He received aspirin 300 mg/day and usual stroke care. Phenytoin was prescribed for seizure control. The MRI of the brain was done at day 12 after admission. The results showed acute infarction of the left pons (Fig. 1), several old lacunar infarcts surrounded by minimal gliosis at the bilateral putamens and thalami as well as, few scatter small old infarcts surrounded by minimal gliosis at bilateral frontal-parietal periventricular white matter without anterior temporal lobe lesion (Fig. 2 A, B, and C). Surprisingly a large number of microbleeds were found throughout the brain (Fig. 2 D, E and F). The total number of cerebral microbleeds were 214 and 136 in lobar areas according to Microbleeds Anatomical Rating Scale (MARS) [9]. After comprehensive reviewed of vascular risk factors, his HbA1C was 5.5% and serum LDL was 79 mg/dL. Likewise, his blood pressures have been well-controlled. All of these risk factors cannot explain his symptoms and MRI findings. The diagnosis of CADASIL was suspected and confirmed by molecular genetic testing revealing homozygous known pathologic variants, c.1672C>T (p.Arg558Cys), in NOTCH3 gene. His clinical symptoms deteriorated, and he died of tracheobronchitis with secretion obstruction.

We reported a patient with history of unexplained progressive cognitive impairment and mood disorder who presented to our institution with recurrent seizures and acute ischemic stroke. The brain MRI findings demonstrated a large number of cerebral microbleeds which did not correlate with his vascular risk factors. Genetic study discovered homozygous known pathologic variants in NOTCH3 gene.

Cerebral microbleeds are perivascular hemosiderin depositions which can be seen in several conditions including patients with hypertensive arteriopathy, cerebral amyloid angiopathy as well as, CADASIL. Cerebral microbleeds are the important marker of the structural integrity of small blood vessels [10]. In CADASIL the prevalence of cerebral microbleeds ranges from 34% to 75% [3-4, 6-8]. Common locations of cerebral microbleeds are in the thalami, the basal ganglias, the subcortical white matter, the brainstem, the cerebellum and at the gray-white matter junction [7-8]. In this patient, however, the cerebral microbleeds were diffusely distributed throughout the brain. To best of our knowledge this case presented with the largest amounts of cerebral microbleeds ever records. Previous study has shown that the number of cerebral microbleeds in CADASIL are correlating with age [8]. One study in particular reported a higher total number of cerebral microbleeds associated with hemorrhagic stroke, dementia, and urge incontinence after adjusted for age [4].

Current evidences demonstrated that cerebral microbleeds are associated with poor functional outcome and help identifying a severe form of CADASIL [6]. While the exact underlying pathophysiology of CADASIL has yet to be identified, recent studies have shown endothelial dysfunction and impaired smooth muscle cell relaxation in small cerebral blood vessel. We consider a large number of cerebral microbleeds in this case are caused by homozygous state and perhaps uncontrolled diabetes and hypertension before he follows up at our hospital. This pathogenic variant, p.Arg558Cys, was found in homozygous state in only two Portuguese patients with CADASIL. One of them had a more severe and early phenotype [11]. Among the other etiologies of cerebral microbleeds, cerebral amyloid angiopathy should also be considered but in this case, he had no evidence of lobar hemorrhage and in contrast to CADASIL, cerebral microbleeds in amyloid angiopathy usually spare the deep gray matter and the brainstem.

Seizures are uncommon symptoms which can be found in approximately 6% to 10% of patients with CADASIL [2-4]. The underlying pathophysiology of seizure in this case has yet to be defined. Nonetheless, there is an evidence to suggest that white matter lesions near the cortex are epileptogenic [12-13]. We believe that our patient developed seizures because he had with a large number of cerebral mibrobleeds in cortical regions.

In summary, we presented a case of CADASIL to raises the awareness of this rare and devastating condition. We demonstrated that acute ischemic stroke in patient with classic vascular risk factors can be caused by other uncommon condition. We have to think more broadly especially when patients have an unexpected clinical presentations or unexpected diagnostic study results as seizures and a large number of cerebral microbleeds in this patient. Finally, we could be investigated etiology of mood disorders and cognitive impairment especially early onset presentation.

CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; MRI: Magnetic resonance imaging; CT: Computed tomography; HbA1C: Hemoglobin A1C; LDL: Low-density lipoprotein

Ethics approval and consent for publication

The study was approved by Prapokklao Hospital Ethics Committee. The committee’s reference number is CTIREC22 and the patient’s sister gave written informed consent prior to obtain the data.

Consent for publication

Written informed consent was obtained from the patient’s sister for publication of this case report and accompanying images. A copy of the written consent is available for review by the editor of this journal.

Availability of data and material

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Funding

None

Author’s contributions

CA examined, evaluated the patient and written the manuscript. DS interpreted the MRI finding and manuscript revision. SC interpreted of the clinical data and manuscript revision. All authors read and approved the final manuscript.

Acknowledgements

The authors would like to thank Dr. Chanin Limwongse for the genetic test and Dr.Ruchaniboon Parichartkanon for proof reading the article.

Author’s information

¹Division of Neurology, Department of Medicine, Prapokklao Hospital, Affiliate with Faculty of Medicine, Chulalongkorn University. Address: 38 Leab Noen Rd, Tambon Wat Mai, Mueang District, Chantaburi Province, 22000, Thailand

²Associate Professor, Department of Radiology, Siriraj Hospital, Faculty of Medicine, Mahidol University. Address: 2 Prannok Rd, Bangkoknoi, Bangkok, 10700, Thailand

³Assiatance Professor, Division of Medical Genetic, Department of Medicine, University of Washington, USA Address: 1959 NE Pacific St. Seattle, WA, USA 981957720

Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL: a hereditary adult-onset condition causing stroke and dementia. Nature.1996;383:707-10.
Dichgans M, Mayer M, Uttner I, Brüning R, Müller‐Höcker J, Rungger G, et al. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann Neurol.1998; 44:731-9.
Bersano A, Bedini G, Markus HS, Vitali P, Tibaldi EC, Taroni F, et al. The role of clinical and neuroimaging features in the diagnosis of CADASIL. J Neurol. 2018;265: 2934-43.
Nannucci S, Rinnoci V, Pracucci G, MacKinnon AD, Pescini F, Adib-Samii P, et al. (2018) Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients. PLoSONE 13(1): e0190878.https://doi.org/10.1371/ journal. pone.0190878
O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001; 56:628–34.
Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H,et al. Cerebral microbleeds and the risk of incident ischemic stroke in CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). Stroke. 2017; 48:2699–703.
Lee JS, Ko KH, Oh JH, Park JH, Lee HK, Floriolli D, et al. Cerebral microbleeds, hypertension, and intracerebral hemorrhage in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Frontiers in Neurology. 8(MAY). https://doi.org/10.3389/fneur.2017.00203
Dichgans M, Holtmannspötter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: A gradient-echo magnetic resonance imaging and autopsy study. Stroke. 2002; 33:67–71.
Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, & Werring, et al. The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology. 2009; 73:1759–66.
Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006; 37:550–5.
Lopes-de-Almeida M, Ramos L, Cordeiro G, Almeida R, Sa J, Saraiva JM. A portuguese family with CADASIL diagnosis with anticipation age of onset observed. Poster presented at 44th Genetics Conference Doutor Jacinto Magalhães; 2015 Feb 20; Porto, Portugal.
Oh JH, Kang BS, Choi JC. CADASIL initially presented with a seizure. J Epilepsy Res. 2016; 6:106-8.
Velizarova R, Mourand I, Serafini A, Crespel A, Gelisse P. Focal epilepsy as first symptoms in CADASIL. Seizure. 2001; 20:502-4.